Stock RV6 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Charles River Laboratories International, Inc. Xetra

Equities

RV6

US1598641074

Real-time Estimate Tradegate
Other stock markets
 03:10:28 2024-06-21 pm EDT 		5-day change 1st Jan Change
197 EUR -8.74% Intraday chart for Charles River Laboratories International, Inc. 0.00% 0.00%
Jun. 17 Charles River Laboratories, Captain T Cell Enter Manufacturing Deal MT
Jun. 17 Charles River Laboratories International, Inc and Captain T Cell Announce Plasmid DNA and Viral Vector Manufacturing Alliance for Gene-Modified Cell Therapy CI

Other languages

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Charles River Laboratories, Captain T Cell Enter Manufacturing Deal
Charles River Laboratories International, Inc and Captain T Cell Announce Plasmid DNA and Viral Vector Manufacturing Alliance for Gene-Modified Cell Therapy
RECOMENDACIONES DE LOS ANALISTAS EE.UU./UK : Lyft, Amazon, Fedex, Xpo, Vail Resorts, Unilever...
Charles River Laboratories Opens New Contract Vivarium Space in Massachusetts
RECOMENDACIONES DE LOS ANALISTAS EE.UU./UK : American Airlines, Salesforce, Five Below, Tesla, Okta...
Charles River Laboratories Expands Access to CRADL® Contract Vivarium Space in Somerville
Charles River Laboratories, Sanofi Collaborating to Develop Non-Animal Virtual Control Groups for Preclinical Trials
Charles River Laboratories International, Inc. Launches Viral Vector Tech Transfer Program to Safeguard Gene Therapy Development
Declaration of Voting Results of Charles River Laboratories International Inc
Charles River Laboratories International Q1 Non-GAAP Earnings Rise, Revenue Fall; Maintains Full Year 2024 Earnings Guidance
Charles River Laboratories International, Inc. Reports Earnings Results for the First Quarter Ended March 30, 2024
Stocks Down Pre-Bell Ahead of Latest Earnings Results; Asia, Europe Churn
Charles River Laboratories International, Inc. Revises Financial Guidance for 2024
China trade heats up, UK rates in view
FibroBiologics, Inc. Plans to Collaborate with Charles River Laboratories to Manufacture Fibroblast-Based Spheroids
Charles River Laboratories Files Supplement to Definitive Proxy Statement with the Securities and Exchange Commission
Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing
Charles River Laboratories International, Inc. and Deciphex Limited Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology
Charles River Laboratories, Axovia Therapeutics Collaborate on Developing Rare Disease Gene Therapies
Charles River Laboratories International, Inc. Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CRL Stock
  4. RV6 Stock
  5. News Charles River Laboratories International, Inc.
  6. Other languages